+
データを開く
-
基本情報
登録情報 | データベース: PDB / ID: 7obk | ||||||
---|---|---|---|---|---|---|---|
タイトル | Crystal structure of 14-3-3 sigma in complex with PKR phosphopeptide | ||||||
![]() |
| ||||||
![]() | SIGNALING PROTEIN / 14-3-3 protein protein-peptide complex | ||||||
機能・相同性 | ![]() Inhibition of PKR / regulation of NLRP3 inflammasome complex assembly / response to interferon-alpha / negative regulation of osteoblast proliferation / regulation of hematopoietic progenitor cell differentiation / positive regulation of stress-activated MAPK cascade / protein phosphatase regulator activity / SUMOylation of immune response proteins / regulation of hematopoietic stem cell proliferation / regulation of hematopoietic stem cell differentiation ...Inhibition of PKR / regulation of NLRP3 inflammasome complex assembly / response to interferon-alpha / negative regulation of osteoblast proliferation / regulation of hematopoietic progenitor cell differentiation / positive regulation of stress-activated MAPK cascade / protein phosphatase regulator activity / SUMOylation of immune response proteins / regulation of hematopoietic stem cell proliferation / regulation of hematopoietic stem cell differentiation / regulation of translational initiation / negative regulation of viral genome replication / regulation of epidermal cell division / protein kinase C inhibitor activity / positive regulation of epidermal cell differentiation / keratinocyte development / keratinization / regulation of cell-cell adhesion / cAMP/PKA signal transduction / Regulation of localization of FOXO transcription factors / keratinocyte proliferation / phosphoserine residue binding / Activation of BAD and translocation to mitochondria / negative regulation of keratinocyte proliferation / establishment of skin barrier / negative regulation of protein localization to plasma membrane / Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex / SARS-CoV-2 targets host intracellular signalling and regulatory pathways / endoplasmic reticulum unfolded protein response / negative regulation of stem cell proliferation / SARS-CoV-1 targets host intracellular signalling and regulatory pathways / RHO GTPases activate PKNs / positive regulation of chemokine production / negative regulation of protein kinase activity / positive regulation of protein localization / antiviral innate immune response / positive regulation of cell adhesion / protein sequestering activity / cellular response to amino acid starvation / negative regulation of innate immune response / protein export from nucleus / TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest / release of cytochrome c from mitochondria / positive regulation of cytokine production / positive regulation of protein export from nucleus / stem cell proliferation / Translocation of SLC2A4 (GLUT4) to the plasma membrane / TP53 Regulates Metabolic Genes / non-membrane spanning protein tyrosine kinase activity / non-specific protein-tyrosine kinase / eukaryotic translation initiation factor 2alpha kinase activity / positive regulation of non-canonical NF-kappaB signal transduction / positive regulation of NF-kappaB transcription factor activity / PKR-mediated signaling / Evasion by RSV of host interferon responses / ISG15 antiviral mechanism / response to virus / intrinsic apoptotic signaling pathway in response to DNA damage / Interferon alpha/beta signaling / kinase activity / intracellular protein localization / double-stranded RNA binding / regulation of protein localization / protein autophosphorylation / positive regulation of cell growth / defense response to virus / non-specific serine/threonine protein kinase / regulation of cell cycle / protein kinase activity / negative regulation of translation / positive regulation of MAPK cascade / protein phosphorylation / ribosome / cadherin binding / translation / negative regulation of cell population proliferation / protein serine kinase activity / protein serine/threonine kinase activity / negative regulation of apoptotic process / protein kinase binding / perinuclear region of cytoplasm / negative regulation of transcription by RNA polymerase II / signal transduction / extracellular space / RNA binding / extracellular exosome / nucleoplasm / ATP binding / identical protein binding / nucleus / membrane / cytosol / cytoplasm 類似検索 - 分子機能 | ||||||
生物種 | ![]() | ||||||
手法 | ![]() ![]() | ||||||
![]() | Centorrino, F. / Andlovic, B. / Ottmann, C. | ||||||
資金援助 | European Union, 1件
| ||||||
![]() | ![]() タイトル: IFN alpha primes cancer cells for Fusicoccin-induced cell death via 14-3-3 PPI stabilization. 著者: Andlovic, B. / Heilmann, G. / Ninck, S. / Andrei, S.A. / Centorrino, F. / Higuchi, Y. / Kato, N. / Brunsveld, L. / Arkin, M. / Menninger, S. / Choidas, A. / Wolf, A. / Klebl, B. / Kaschani, F. ...著者: Andlovic, B. / Heilmann, G. / Ninck, S. / Andrei, S.A. / Centorrino, F. / Higuchi, Y. / Kato, N. / Brunsveld, L. / Arkin, M. / Menninger, S. / Choidas, A. / Wolf, A. / Klebl, B. / Kaschani, F. / Kaiser, M. / Eickhoff, J. / Ottmann, C. | ||||||
履歴 |
|
-
構造の表示
構造ビューア | 分子: ![]() ![]() |
---|
-
ダウンロードとリンク
-
ダウンロード
PDBx/mmCIF形式 | ![]() | 142.5 KB | 表示 | ![]() |
---|---|---|---|---|
PDB形式 | ![]() | 89.9 KB | 表示 | ![]() |
PDBx/mmJSON形式 | ![]() | ツリー表示 | ![]() | |
その他 | ![]() |
-検証レポート
文書・要旨 | ![]() | 431.9 KB | 表示 | ![]() |
---|---|---|---|---|
文書・詳細版 | ![]() | 432.4 KB | 表示 | |
XML形式データ | ![]() | 15.7 KB | 表示 | |
CIF形式データ | ![]() | 25 KB | 表示 | |
アーカイブディレクトリ | ![]() ![]() | HTTPS FTP |
-関連構造データ
関連構造データ | ![]() 7ob5C ![]() 7ob8C ![]() 7obcC ![]() 7obdC ![]() 7obgC ![]() 7obhC ![]() 7oblC ![]() 7obsC ![]() 7obtC ![]() 7obxC ![]() 7obyC ![]() 4jc3S S: 精密化の開始モデル C: 同じ文献を引用 ( |
---|---|
類似構造データ | 類似検索 - 機能・相同性 ![]() |
-
リンク
-
集合体
登録構造単位 | ![]()
| ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | ![]()
| ||||||||||||
単位格子 |
| ||||||||||||
Components on special symmetry positions |
|
-
要素
#1: タンパク質 | 分子量: 28226.518 Da / 分子数: 1 / 由来タイプ: 組換発現 / 由来: (組換発現) ![]() ![]() ![]() | ||||||
---|---|---|---|---|---|---|---|
#2: タンパク質・ペプチド | 分子量: 1428.465 Da / 分子数: 1 / 由来タイプ: 合成 / 由来: (合成) ![]() 参照: UniProt: P19525, non-specific serine/threonine protein kinase, non-specific protein-tyrosine kinase | ||||||
#3: 化合物 | #4: 水 | ChemComp-HOH / | 研究の焦点であるリガンドがあるか | Y | Has protein modification | Y | |
-実験情報
-実験
実験 | 手法: ![]() |
---|
-
試料調製
結晶 | マシュー密度: 2.46 Å3/Da / 溶媒含有率: 49.95 % |
---|---|
結晶化 | 温度: 277.15 K / 手法: 蒸気拡散法, シッティングドロップ法 詳細: 0.095 M Hepes pH7.3, 25%PEG 400, 0.19 M CaCl2 and 5 % Glycerol |
-データ収集
回折 | 平均測定温度: 100 K / Serial crystal experiment: N |
---|---|
放射光源 | 由来: SEALED TUBE / タイプ: RIGAKU MICROMAX-003 / 波長: 1.5419 Å |
検出器 | タイプ: DECTRIS PILATUS 200K / 検出器: PIXEL / 日付: 2020年9月1日 |
放射 | プロトコル: SINGLE WAVELENGTH / 単色(M)・ラウエ(L): M / 散乱光タイプ: x-ray |
放射波長 | 波長: 1.5419 Å / 相対比: 1 |
反射 | 解像度: 1.8→41.87 Å / Num. obs: 27306 / % possible obs: 99.8 % / 冗長度: 6.2 % / Biso Wilson estimate: 8.95 Å2 / CC1/2: 0.997 / Rmerge(I) obs: 0.088 / Net I/σ(I): 14.3 |
反射 シェル | 解像度: 1.8→1.83 Å / 冗長度: 5 % / Rmerge(I) obs: 0.283 / Mean I/σ(I) obs: 4.5 / Num. unique obs: 1311 / CC1/2: 0.921 / % possible all: 97.8 |
-
解析
ソフトウェア |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
精密化 | 構造決定の手法: ![]() 開始モデル: 4JC3 解像度: 1.8→41.86 Å / SU ML: 0.1522 / 交差検証法: FREE R-VALUE / σ(F): 1.5 / 位相誤差: 16.1356 / 立体化学のターゲット値: GeoStd + Monomer Library
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
溶媒の処理 | 減衰半径: 0.9 Å / VDWプローブ半径: 1.11 Å / 溶媒モデル: FLAT BULK SOLVENT MODEL | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
原子変位パラメータ | Biso mean: 11.81 Å2 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
精密化ステップ | サイクル: LAST / 解像度: 1.8→41.86 Å
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
拘束条件 |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
LS精密化 シェル |
|